IAPs and Cell Death
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/82_2016_507
Reference161 articles.
1. Andree M, Seeger JM, Schüll S, Coutelle O et al (2014) BID-dependent release of mitochondrial SMAC dampens XIAP-mediated immunity against Shigella. EMBO J 33:2171–2187
2. Bergmann A, Agapite J, McCall K, Steller H (1998) The Drosophila Gene Hid is a direct molecular target of ras-dependent survival signaling. Cell 95:331–341
3. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC et al (2008) cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689–700
4. Bertrand MJ, Doiron K, Labbé K, Korneluk RG et al (2009) Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity 30(6):789–801
5. Bertrand MJ, Lippens S, Staes A, Gilbert B et al (2011) cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4). PLoS ONE 6:e22356
Cited by 34 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. New insights into the cytotoxic effects of Thymus vulgaris essential oil on the human triple-negative breast cancer cell line MDA-MB-231;Toxicology in Vitro;2023-12
2. Progress in the study of molecular mechanisms of cell pyroptosis in tumor therapy;International Immunopharmacology;2023-05
3. A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis;Inflammopharmacology;2023-03-03
4. Caspase‐8‐driven apoptotic and pyroptotic crosstalk causes cell death and IL‐1β release in X‐linked inhibitor of apoptosis (XIAP) deficiency;The EMBO Journal;2023-01-17
5. X‐linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL;EMBO Molecular Medicine;2022-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3